The Reyes Syndrome Rule Was Withdrawn From OMB Review By The Secretary Of HHS. The assertion that Jim Tozzi rejected the proposed Reyes Syndrome labeling is completely inaccurate. The facts are, as demonstrated in the record, as follows:

(1) Sept 20 1982 The Secretary of HHS sent a proposed labeling regulation to OMB.

(2) Nov 8 1982 The American Academy of Pediatrics announces" "Labeling aspirin-containing preparations as contraindicted in the treatment of influenza or chicken pox should be delayed until more conclusive evidence of the association of aspirin administration and Reye's Syndrome is shown by further investigation."

(3) Nov 18 1982 The Secretary of HHS withdrew the rule from OMB review.

The record clearly demonstrates that Tozzi did not delay the implementation of the review for years.

Also see this link https://www.thecre.com/emerging/tozzi_blog01.html.